EnteroBiotix secure key additional MHRA license and announces regulatory milestones

MHRA MIA (IMP) license enables international clinical trial manufacture and distribution  EnteroBiotix meets with European Medicines Agency Innovation Task Force (ITF) in Amsterdam Founding member of Intestinal Microbiome Medicine European Task Group (IMM-ETG) Aberdeen, Scotland and Cambridge, MA, 19 June 2019 – EnteroBiotix, a leading clinical stage microbiome therapeutics company headquartered in Aberdeen, Scotland, today […]

Continue reading